Innovation Pharma Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease Read more
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology Read more
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC Read more
Reata Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease Read more